You can check out the annual or quarterly balance sheets of OKYO Pharma Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026H2

FY2025H2

FY2025H1

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

Total equity

Cash, cash equivalents and short-term investments

1250.43%27.23M

88.78%1.56M

-35.22%793.12K

-79.97%643.11K

133.73%1.22M

88.90%3.21M

-81.69%523.79K

-52.73%1.70M

-33.88%2.86M

2392.64%3.60M

10136.41%4.33M

-62.11%144.27K

-95.69%42.25K

--380.72K

--980.67K

- Cash and cash equivalents

856.99%19.30M

88.78%1.56M

-35.22%793.12K

-79.97%643.11K

133.73%1.22M

88.90%3.21M

-81.69%523.79K

-52.73%1.70M

-33.88%2.86M

2392.64%3.60M

10136.41%4.33M

-62.11%144.27K

-95.69%42.25K

--380.72K

--980.67K

-Short-term investments

--7.93M

----

Receivables

-90.75%225.66K

225.17%1.89M

222.04%1.22M

-41.91%451.85K

-5.97%379.22K

39.91%777.90K

127.97%403.30K

1296.35%556.01K

486.75%176.91K

-80.07%39.82K

-90.75%30.15K

195.49%199.82K

3537.33%325.99K

--67.62K

--8.96K

-Accounts and notes receivable

2.35%5.95K

-19.43%4.50K

6.15%3.62K

-98.39%4.34K

1.89%3.41K

2146.97%270.54K

34.65%3.34K

412.66%12.04K

178.86%2.48K

-98.28%2.35K

115045.54%890.32

3979.19%136.31K

--0.77

--3.34K

----

-Other receivables

--190.82K

----

-100.00%0.00

197.25%52.85K

11.23%14.44K

-94.44%17.78K

--12.98K

--319.51K

----

Prepaid expenses

-6.86%271.16K

73.19%225.36K

33.73%256.64K

-25.54%101.21K

-49.80%191.91K

-69.63%135.92K

1953.47%382.26K

3969.50%447.61K

65.90%18.62K

182.68%11.00K

-41.43%11.22K

-67.47%3.89K

449.90%19.16K

--11.96K

--3.48K

Total current assets

483.99%27.73M

138.98%3.68M

26.49%2.27M

-71.00%1.20M

37.12%1.80M

52.58%4.12M

-57.15%1.31M

-25.87%2.70M

-30.03%3.06M

948.00%3.65M

1027.15%4.37M

-24.40%347.98K

-60.99%387.41K

--460.31K

--993.11K

Non-current assets

Net Fixed Assets

217.42%8.34K

-39.25%2.04K

-55.44%1.73K

-54.51%2.61K

-6.51%3.89K

74.16%5.73K

-91.23%4.16K

-93.98%3.29K

168.57%47.47K

190.07%54.62K

3261.65%17.68K

2709.43%18.83K

--525.79

--670.20

----

-Fixed Assets

46.27%19.84K

0.32%10.50K

--8.41K

-33.03%8.14K

----

97.50%12.16K

-83.05%8.35K

-88.97%6.15K

168.36%49.28K

190.52%55.81K

2242.06%18.36K

2294.25%19.21K

--784.04

--802.34

----

-Accumulated depreciation

5.12%11.50K

18.94%8.46K

--6.68K

-13.89%5.54K

----

124.29%6.43K

131.83%4.19K

140.25%2.87K

162.96%1.81K

212.89%1.19K

166.26%687.64

188.54%381.29

--258.25

--132.14

----

Total non-current assets

217.42%8.34K

-39.25%2.04K

-55.44%1.73K

-54.51%2.61K

-6.51%3.89K

74.16%5.73K

-91.23%4.16K

-93.98%3.29K

168.57%47.47K

190.07%54.62K

3261.65%17.68K

2709.43%18.83K

--525.79

--670.20

----

Total assets

483.85%27.73M

138.59%3.68M

26.31%2.27M

-70.98%1.20M

36.98%1.80M

52.60%4.13M

-57.67%1.31M

-26.88%2.71M

-29.22%3.10M

909.10%3.70M

1030.18%4.38M

-20.43%366.81K

-60.94%387.93K

--460.98K

--993.11K

Liabilities

Current liabilities

-Other payables

-99.86%1.75K

105.03%948.32K

-8.78%358.03K

-46.83%359.76K

322.26%392.48K

2185.16%676.55K

503.79%92.95K

--29.61K

-40.49%15.39K

-100.00%0.00

1627.17%25.87K

175.53%44.02K

--1.50K

--15.98K

----

Accrued expenses

306.55%1.99M

-54.40%378.58K

----

-56.61%645.70K

----

319.02%1.49M

85.79%348.97K

-53.46%355.18K

793.59%187.83K

2994.29%763.21K

6.86%21.02K

118.29%24.67K

-67.81%19.67K

--11.30K

--61.10K

Short-term debt and lease liabilities

----

-99.92%1.45K

-100.00%0.00

--1.80M

--1.76M

-100.00%0.00

535.20%19.05K

471.54%17.82K

--3.00K

--3.12K

----

-Short-term debt

----

-99.92%1.45K

-100.00%0.00

--1.80M

--1.76M

----

-Short-term lease liabilities

----

-100.00%0.00

535.20%19.05K

471.54%17.82K

--3.00K

--3.12K

----

Other current liabilities

-99.86%1.75K

105.03%948.32K

-8.78%358.03K

-46.83%359.76K

322.26%392.48K

2185.16%676.55K

503.79%92.95K

--29.61K

-40.49%15.39K

-100.00%0.00

1627.17%25.87K

175.53%44.02K

--1.50K

--15.98K

----

Total current liabilities

-4.14%11.43M

24.34%9.23M

28.34%8.08M

0.20%5.77M

301.02%6.29M

576.34%5.76M

359.54%1.57M

-4.43%851.66K

40.32%341.54K

104.23%891.16K

-52.38%243.39K

68.56%436.35K

287.24%511.10K

--258.87K

--131.99K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Total non-current liabilities

----

-100.00%0.00

87.44%26.07K

106.97%33.73K

--13.91K

--16.30K

----

Total liabilities

-4.14%11.43M

24.34%9.23M

28.34%8.08M

0.20%5.77M

301.02%6.29M

576.34%5.76M

326.96%1.57M

-7.92%851.66K

42.87%367.60K

104.33%924.89K

-49.66%257.30K

74.85%452.65K

287.24%511.10K

--258.87K

--131.99K

Shareholders' equity

Common equity

21.24%233.28M

0.67%148.95M

13.48%119.98M

7.32%115.08M

57.61%105.73M

63.95%107.23M

15.56%67.08M

18.78%65.40M

1.89%58.05M

4.60%55.06M

6.88%56.97M

-2.83%52.64M

1.31%53.30M

--54.17M

--52.61M

Retained earnings

-8.76%-200.94M

-0.35%-143.02M

-14.58%-116.66M

-11.11%-110.85M

-51.30%-101.81M

-57.00%-99.77M

-21.66%-67.29M

-21.53%-63.55M

-4.66%-55.31M

0.83%-52.29M

1.09%-52.85M

2.30%-52.73M

-3.23%-53.43M

---53.97M

---51.75M

Capital reserves

32.17%3.80M

-53.98%2.23M

27.55%4.15M

27.86%3.77M

58.86%3.26M

86.54%2.95M

55.94%2.05M

-76.39%1.58M

-80.00%1.31M

392.01%6.69M

6254.02%6.57M

2626.03%1.36M

-64.42%103.42K

--49.87K

--290.67K

Gains losses not affecting retained earnings

-8.24%-16.04M

-1.41%-11.47M

-12.65%-9.47M

3.21%-8.80M

-19374.13%-8.41M

-1338826.43%-9.09M

-1026.99%-43.18K

-116.13%-678.91

-267.52%-3.83K

102.00%4.21K

--2.29K

--2.08K

----

Total equity

327.50%16.31M

5.61%-5.55M

-29.15%-5.81M

-180.61%-4.57M

-1655.77%-4.49M

-187.85%-1.63M

-109.36%-256.00K

-33.19%1.86M

-33.72%2.74M

3334.66%2.78M

3450.82%4.13M

-142.47%-85.84K

-114.30%-123.16K

--202.10K

--861.13K

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing OKYO stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does OKYO Pharma Ltd Have?



In its most recent quarterly, OKYO Pharma Ltd had 19.30M in cash and cash equivalents.

What Are OKYO Pharma Ltd's Total Assets?



As of the latest reported quarter, OKYO Pharma Ltd's total assets were 28.17M, consisting of 28.16M in current assets and 8.47K in non-current assets.

How Much Shareholders' Equity Does OKYO Pharma Ltd Have?



OKYO Pharma Ltd reported 16.56M in total shareholders' equity as of the latest reported quarter.